Q fever in the Netherlands from 2007 to 2010

Netherlands Journal of Medicine

Volumn 68, Issue 12, 2010, Pages 382-387

  Delsing, C E ^a   Kullberg, B J ^a   Bleeker Rovers, C P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Coxiella; Q fever; The Netherlands

Indexed keywords

CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; HYDROXYCHLOROQUINE;

COMMUNITY ACQUIRED PNEUMONIA; CONTAMINATION; COXIELLA BURNETII; DIZZINESS; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; EPIDEMIC; FATIGUE; HEADACHE; HOSPITALIZATION; HUMAN; NAUSEA; NETHERLANDS; NONHUMAN; PHOTOSENSITIVITY; POLYMERASE CHAIN REACTION; PREGNANCY; Q FEVER; RETINA MACULOPATHY; REVIEW; SEROPREVALENCE; VACCINATION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; COXIELLA BURNETII; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; Q FEVER; RISK FACTORS;

EID: 78651501575     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Kosatsky T. Household outbreak of Q-fever pneumonia related to a parturient cat. Lancet. 1984 2;2:1447-9.
2. Tigertt WD, Benenson AS, Gochenour WS. Airborne Q fever. Bacteriol Rev. 1961;25:285-93.
3. van Duynhoven Y, Schimmer B, Van Steenbergen JE, van der Hoek W. The story of human Q fever in the Netherlands. Q fever conference 2010, Breda, 25 Febr. 2010.
4. van Steenbergen JE, Morroy G, Groot CA, Ruikes FG, Marcelis JH, Speelman P. [An outbreak of Q fever in The Netherlands--possible link to goats]. Ned Tijdschr Geneeskd. 2007;151(36):1998-2003.
5. Schimmer B, ter Schegget R, Wegdam M, Zuchner L, De Bruin A, Schneeberger PM, et al. The use of a geographic information system to identify a dairy goat farm as the most likely source of an urban Q-fever outbreak. BMC Infect Dis. 2010;10:69.
6. Koene RP, Schimmer B, Rensen H, Biesheuvel M, De Bruin A, Lohuis A, et al. A Q fever outbreak in a psychiatric care institution in The Netherlands. Epidemiol Infect. 2010;1-6.
7. Hunink JE, Veenstra T, van der Hoek W, Droogers P. Q fever transmission to humans and local environmental conditions. 2010, FutureWater rapport 90. FutureWater, Wageningen.
8. Porten K, Rissland J, Tigges A, Broll S, Hopp W, Lunemann M, et al. A super-spreading ewe infects hundreds with Q fever at a farmers' market in Germany. BMC Infect Dis. 2006;6:147.
9. Dupuis G, Petite J, Peter O, Vouilloz M. An important outbreak of human Q fever in a Swiss Alpine valley. Int J Epidemiol. 1987;16(2):282-7.
10. Rousset E, Durand B, Champion JL, Prigent M, Dufour P, Forfait C, et al. Efficiency of a phase 1 vaccine for the reduction of vaginal Coxiella burnetii shedding in a clinically affected goat herd. Clin Microbiol Infect. 2009;15(Suppl 2):188-9.
11. Karagiannis I, Schimmer B, Van Lier A, Timen A, Schneeberger P, van Rotterdam B, et al. Investigation of a Q fever outbreak in a rural area of The Netherlands. Epidemiol Infect. 2009;137(9):1283-94.
12. Hatchette TF, Hudson RC, Schlech WF, Campbell NA, Hatchette JE, Ratnam S, et al. Goat-associated Q fever: a new disease in Newfoundland. Emerg Infect Dis. 2001;7(3):413-9.
13. Orr HJ, Christensen H, Smyth B, Dance DA, Carrington D, Paul I, et al. Case-control study for risk factors for Q fever in southwest England and Northern Ireland. Euro Surveill. 2006;11(10):260-2.
14. Raoult D, Marrie T, Mege J. Natural history and pathophysiology of Q fever. Lancet Infect Dis. 2005;5(4):219-26.
15. Schimmer B, Morroy G, Dijkstra F, Schneeberger PM, Weers-Pothoff G, Timen A, et al. Large ongoing Q fever outbreak in the south of The Netherlands, 2008. Euro Surveill. 2008;13(31).
16. van der Hoek W, Dijkstra F, Schimmer B, Schneeberger PM, Vellema P, Wijkmans C, et al. Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill. 2010;15(12):19526.
17. Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T, Raoult D. Risks factors and prevention of Q fever endocarditis. Clin Infect Dis. 2001;33(3):312-6.
18. Raoult D, Tissot-Dupont H, Foucault C, Gouvernet J, Fournier PE, Bernit E, et al. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore). 2000;79(2):109-23.
19. Wever PC, Arts CH, Groot CA, Lestrade PJ, Koning OH, Renders NH. [Screening for chronic Q fever in symptomatic patients with an aortic aneurysm or prosthesis.]. Ned Tijdschr Geneeskd. 2010;154(28):A2122.
20. Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A. Q Fever during pregnancy: a cause of poor fetal and maternal outcome. Ann N Y Acad Sci. 2009;1166:79-89.
21. Rey D, Obadia Y, Tissot-Dupont H, Raoult D. Seroprevalence of antibodies to Coxiella burnetti among pregnant women in South Eastern France. Eur J Obstet Gynecol Reprod Biol. 2000;93(2):151-6.
22. Baud D, Peter O, Langel C, Regan L, Greub G. Seroprevalence of Coxiella burnetii and Brucella abortus among pregnant women. Clin Microbiol Infect. 2009;15(5):499-501.
23. Meekelenkamp JC, Notermans DW, Rietveld A, Marcelis JH, Schimmer B, Reimerink JHJ, et al. Seroprevalentie van Coxiella burnetii bij zwangeren in Noord-Brabant in 2007. Infectieziekten Bulletin. 2009;(2):57-61.
24. Wildman MJ, Smith EG, Groves J, Beattie JM, Caul EO, Ayres JG. Chronic fatigue following infection by Coxiella burnetii (Q fever): ten-year follow-up of the 1989 UK outbreak cohort. QJM. 2002;95(8):527-38.
25. Marmion BP, Shannon M, Maddocks I, Storm P, Penttila I. Protracted debility and fatigue after acute Q fever. Lancet. 1996;347(9006):977-8.
26. Limonard GJ, Peters JB, Nabuurs-Franssen MH, Weers-Pothoff G, Besselink R, Groot CA, et al. Detailed analysis of health status of Q fever patients 1 year after the first Dutch outbreak: a case-control study. QJM. 2010; in press.
27. Penttila IA, Harris RJ, Storm P, Haynes D, Worswick DA, Marmion BP. Cytokine dysregulation in the post-Q-fever fatigue syndrome. QJM. 1998;91(8):549-60.
28. Helbig KJ, Heatley SL, Harris RJ, Mullighan CG, Bardy PG, Marmion BP. Variation in immune response genes and chronic Q fever. Concepts: preliminary test with post-Q fever fatigue syndrome. Genes Immun. 2003;4(1):82-5.
29. Helbig K, Harris R, Ayres J, Dunckley H, Lloyd A, Robson J, et al. Immune response genes in the post-Q-fever fatigue syndrome, Q fever endocarditis and uncomplicated acute primary Q fever. QJM. 2005;98(8):565-74.
30. Harris RJ, Storm PA, Lloyd A, Arens M, Marmion BP. Long-term persistence of Coxiella burnetii in the host after primary Q fever. Epidemiol Infect. 2000;124(3):543-9.
31. Marmion BP, Sukocheva O, Storm PA, Lockhart M, Turra M, Kok T, et al. Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host--implications for post Q fever infection fatigue syndrome and other chronic sequelae. QJM. 2009;102(10):673-84.
32. Arashima Y, Kato K, Komiya T, Kumasaka K, Matsukawa Y, Murakami M, et al. Improvement of chronic nonspecific symptoms by long-term minocycline treatment in Japanese patients with Coxiella burnetii infection considered to have post-Q fever fatigue syndrome. Intern Med. 2004;43(1):49-54.
33. Iwakami E, Arashima Y, Kato K, Komiya T, Matsukawa Y, Ikeda T, et al. Treatment of chronic fatigue syndrome with antibiotics: pilot study assessing the involvement of Coxiella burnetii infection. Intern Med. 2005;44(12):1258-63.
34. Fournier PE, Marrie TJ, Raoult D. Diagnosis of Q fever. J Clin Microbiol. 1998;36(7):1823-34.
35. Schneeberger PM, Hermans MH, van Hannen EJ, Schellekens JJ, Leenders AC, Wever PC. Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clin Vaccine Immunol. 2010;17(2):286-90.
36. Wegdam-Blans MC, Nabuurs-Franssen MN, Horrevorts AM, Peeters MF, Schneeberger PM, Bijlmer HA. [Laboratory diagnosis of acute Q fever]. Ned Tijdschr Geneeskd. 2010;154(37):A2388.
37. van der Hoek W, Dijkstra F, Wijers N, Rietveld A, Wijkmans CJ, van Steenbergen JE, et al. [Three years of Q fever in the Netherlands: faster diagnosis]. Ned Tijdschr Geneeskd. 2010;154(25):A1845.
38. Delsing CE, Kullberg BJ. Q fever in the Netherlands: a concise overview and implications of the largest ongoing outbreak. Neth J Med. 2008;66(9):365-7.
39. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Jr., Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633-8.
40. Dupont HT, Thirion X, Raoult D. Q fever serology: cutoff determination for microimmunof luorescence. Clin Diagn Lab Immunol. 1994;1(2):189-96.
41. Ake JA, Massung RF, Whitman TJ, Gleeson TD. Difficulties in the diagnosis and management of a US servicemember presenting with possible chronic Q fever. J Infect. 2010;60(2):175-7.
42. Rolain JM, Maurin M, Raoult D. Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii. Antimicrob Agents Chemother. 2001;45(1):301-2.
43. Gikas A, Kofteridis DP, Manios A, Pediaditis J, Tselentis Y. Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob Agents Chemother. 2001;45(12):3644-6.
44. Maltezou HC, Raoult D. Q fever in children. Lancet Infect Dis. 2002;2(11):686-91.
45. Schouten JA, Prins JM, Bonten M, Degener JE, Janknegt R, Hollander JM, et al. [Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with communityacquired pneumonia]. Ned Tijdschr Geneeskd. 2005;149(45):2495-500.
46. Lassche S, Schrauwen MMWP, Rietveld A, Wijkmans CJ. Huisartsen in hoog-risicogebieden alert op q koorts. Infectieziekten Bulletin. 2010;2:45-9.
47. Raoult D, Houpikian P, Tissot DH, Riss JM, Arditi-Djiane J, Brouqui P. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med. 1999;159(2):167-73.
48. Maurin M, Benoliel AM, Bongrand P, Raoult D. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. J Infect Dis. 1992;166(5):1097-102.
49. Ackland JR, Worswick DA, Marmion BP. Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990. Med J Aust. 1994;160(11):704-8.
50. Zaaijer HL. Q fever in the Netherlands. Health Council of the Netherlands. Human vaccination against Q fever. The Hague: Health Council of the Netherlands, 2010; publication no. 2010/08. ISBN 978-90-5549-809-3.